We're building a better ClinicalTrials.gov. Check it out and tell us what you think!
ClinicalTrials.gov Menu

Interferon α2a Versus Cyclosporine for Refractory Behçet's Disease Uveitis

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT03209219
Recruitment Status : Completed
First Posted : July 6, 2017
Last Update Posted : February 23, 2021
Information provided by (Responsible Party):
Meifen Zhang, Peking Union Medical College Hospital

No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : Completed
Actual Primary Completion Date : August 31, 2020
Actual Study Completion Date : January 31, 2021